RecallDepth
Class III Terminated

APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 522 mg, a) 7-count HDPE bottle (NDC 0024-5812-07), b) 30-count HDPE bottle (NDC 0024-5812-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7

This recall has been terminated (originally issued November 5, 2014).

Company
Valeant Pharmaceuticals North America Llc
Recall Initiated
June 5, 2014
Posted
November 5, 2014
Recall Number
D-0053-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
55,650 HDPE bottles
Firm Location
Bridgewater, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Labeling: Incorrect or Missing Package Insert

Distribution

Nationwide

Lot / Code Info

Lot #: a) 13E023P; Exp. 03/16 Lot #: b) 12J063P; Exp. 07/15 12K063P; Exp. 09/15 12K060P; Exp. 07/15 12M073P; Exp. 09/15 13A036P; Exp. 11/15 13B035P; Exp. 11/15 13C046P; Exp. 11/15 13D060P; Exp. 11/15 13E030P; Exp. 03/16 13E031P; Exp. 03/16 13F003P; Exp. 03/16 13K034P; Exp. 03/16 14A001P; Exp. 10/16

More recalls by Valeant Pharmaceuticals North America Llc

View all recalls by this company →

Other recent Class III Drug recalls